scholarly journals Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity

2012 ◽  
Vol 109 (36) ◽  
pp. 14550-14555 ◽  
Author(s):  
J. Di Domizio ◽  
S. Dorta-Estremera ◽  
M. Gagea ◽  
D. Ganguly ◽  
S. Meller ◽  
...  
2017 ◽  
Vol 16 (9) ◽  
pp. 897-902 ◽  
Author(s):  
Cécile Picard ◽  
Alexandre Belot

2009 ◽  
Vol 11 (4) ◽  
pp. R112 ◽  
Author(s):  
Donna L Thibault ◽  
Kareem L Graham ◽  
Lowen Y Lee ◽  
Imelda Balboni ◽  
Paul J Hertzog ◽  
...  

Immunity ◽  
2019 ◽  
Vol 50 (3) ◽  
pp. 591-599.e6 ◽  
Author(s):  
Xin Li ◽  
Meng Deng ◽  
Alex S. Petrucelli ◽  
Cheng Zhu ◽  
Jinyao Mo ◽  
...  

2020 ◽  
Author(s):  
Ole Kristian Greiner-Tollersrud ◽  
Vincent Boehler ◽  
Eva Bartok ◽  
Máté Krausz ◽  
Aikaterini Polyzou ◽  
...  

AbstractDeficiency of adenosine deaminase 2 (DADA2) is a severe, congenital syndrome, which manifests with hematologic, immunologic and inflammatory pathologies. DADA2 is caused by biallelic mutations in ADA2, but the function of ADA2, and the mechanistic link between ADA2 deficiency and the severe inflammatory phenotype remains unclear. Here, we show that monocyte-derived proteomes from DADA2 patients are highly enriched in interferon response proteins. Using immunohistochemistry and detailed glycan analysis we demonstrate that ADA2 is post-translationally modified for sorting to the lysosomes. At acidic, lysosomal pH, ADA2 acts as a novel DNase that degrades cGAS/Sting-activating ligands. Furthermore, we define a clear structure-function relationship for this acidic DNase activity. Deletion of ADA2 increased the production of cGAMP and type I interferons upon exposure to dsDNA, which was reverted by ADA2 overexpression or deletion of STING. Our results identify a new level of control in the nucleic acid sensing machinery and provide a mechanistic explanation for the pathophysiology of autoinflammation in DADA2.One Sentence SummaryADA2 is a lysosomal nuclease controlling nucleic acid sensing and type I interferon production.


2021 ◽  
Vol 10 (3) ◽  
pp. 532
Author(s):  
Erika Huijser ◽  
Marjan A. Versnel

Primary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease characterized by dryness of the eyes and mucous membranes, which can be accompanied by various extraglandular autoimmune manifestations. The majority of patients exhibit persistent systemic activation of the type I interferon (IFN) system, a feature that is shared with other systemic autoimmune diseases. Type I IFNs are integral to anti-viral immunity and are produced in response to stimulation of pattern recognition receptors, among which nucleic acid (NA) receptors. Dysregulated detection of endogenous NAs has been widely implicated in the pathogenesis of systemic autoimmune diseases. Stimulation of endosomal Toll-like receptors by NA-containing immune complexes are considered to contribute to the systemic type I IFN activation. Accumulating evidence suggest additional roles for cytosolic NA-sensing pathways in the pathogenesis of systemic autoimmune rheumatic diseases. In this review, we will provide an overview of the functions and signaling of intracellular RNA- and DNA-sensing receptors and summarize the evidence for a potential role of these receptors in the pathogenesis of pSS and the sustained systemic type I IFN activation.


Sign in / Sign up

Export Citation Format

Share Document